Efficiency of Trekrezan in experimental bronchopneumonia in rats
I. V. Zarubina, A. V. Bolekhan, P. D. Shabanov · 2006 · Bull Exp Biol Med 142(2):205–208
What does this source report?
The abstract reports altered lymphocyte immune measures, lower lactate and higher ATP and pyruvate in lung tissue and blood lymphocytes.
- Population and setting
- Rats with experimental acute bronchopneumonia
- Evidence type
- Animal / experimental
- Preparation
- See the original report; formulation details require verification.
- Source language
- Russian; English abstract where indicated
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- Preclinical disease model; no human pneumonia benefit established. Programme overlap with later dissertation and review is possible.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Citation and available abstract or selected source passages checked; complete methods and risk-of-bias appraisal pending.
Recorded source-check date: 2026-09-30. This date does not imply a completed systematic review.
Cite and trace this record
Original source: I. V. Zarubina, A. V. Bolekhan, P. D. Shabanov. Efficiency of Trekrezan in experimental bronchopneumonia in rats Bull Exp Biol Med 142(2):205–208 2006.
Molekul research summary: https://molekul.io/research/trek-17369940. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry